Literature DB >> 16141656

Effect of autonomic nervous function on QT interval in dogs.

Takuma Harada1, Junko Abe, Motohiro Shiotani, Yoshimasa Hamada, Ikuo Horii.   

Abstract

The effects of drugs on the QT interval should be evaluated precisely in the early stages of drug development because QT prolongation can trigger the so-called torsades de pointes, a life-threatening polymorphic ventricular tachycardia. It has been reported that the QT interval is affected by autonomic nervous tone besides the heart rate. In this study, we investigated the direct effect of autonomic nervous tone on the QT interval using the parameters of heart rate variability in dogs, when the RR interval was constant (400 or 700 msec). Our results showed that the QT interval at the high HF (high vagal tone) or low LF/HF ratio (low sympathetic tone) was longer than that at the low HF (low vagal tone) or high LF/HF ratio (high sympathetic tone), when the RR intervals were constant, and that the effect of vagal tone on the QT interval might be somewhat stronger than that of the sympathetic tone. The present observations would support the idea that sympathetic as well as parasympathetic tone regulates QT interval and that QT interval may be controlled physiologically by myocardial autonomic nerves via and not via a sinus node. Therefore, a more precise correction formula of QT interval could be established using autonomic parameters other than RR interval (heart rate), while the QT interval is widely known to be dependent on the RR interval or heart rate.

Entities:  

Mesh:

Year:  2005        PMID: 16141656     DOI: 10.2131/jts.30.229

Source DB:  PubMed          Journal:  J Toxicol Sci        ISSN: 0388-1350            Impact factor:   2.196


  9 in total

1.  Changes in ventricular repolarization duration during typical daily emotion in patients with Long QT syndrome.

Authors:  Richard D Lane; Wojciech Zareba; Harry T Reis; Derick R Peterson; Arthur J Moss
Journal:  Psychosom Med       Date:  2010-12-23       Impact factor: 4.312

2.  The effects of intravenous ciprofloxacin on the electrocardiogram of healthy dogs.

Authors:  Masoud Selk Ghaffari; Reza Parsamehr
Journal:  Vet Res Commun       Date:  2009-09-02       Impact factor: 2.459

3.  QTc interval in takotsubo cardiomyopathy: How the activation of insular cortex interacts.

Authors:  Michiaki Nagai; Keigo Dote; Masaya Kato; Noboru Oda; Eiji Kunita
Journal:  Clin Cardiol       Date:  2018-07-17       Impact factor: 2.882

4.  Insular cortex lesion and autonomic instability in a herpes simplex virus encephalitis patient.

Authors:  Mai Kikumoto; Michiaki Nagai; Tomohiko Ohshita; Megumi Toko; Masaya Kato; Keigo Dote; Hiroshi Yamashita
Journal:  J Neurovirol       Date:  2018-07-09       Impact factor: 2.643

5.  Translational pharmacokinetic-pharmacodynamic modelling; application to cardiovascular safety data for PF-00821385, a novel HIV agent.

Authors:  Grant Langdon; John D Davis; Lynn M McFadyen; Mark Dewhurst; Neil S Brunton; Jaiessh K Rawal; Piet H Van der Graaf; Neil Benson
Journal:  Br J Clin Pharmacol       Date:  2010-04       Impact factor: 4.335

6.  Olanzapine induced Q-Tc shortening.

Authors:  Saeed Shoja Shafti; Parisa Fallah Jahromi
Journal:  Ther Adv Psychopharmacol       Date:  2014-12

7.  Sudden death associated with QT interval prolongation and KCNQ1 gene mutation in a family of English Springer Spaniels.

Authors:  W A Ware; Y Reina-Doreste; J A Stern; K M Meurs
Journal:  J Vet Intern Med       Date:  2015-03-16       Impact factor: 3.333

8.  Improvement of increased cQTd is associated with heart function in patients with ischemic heart failure.

Authors:  Hui Guo; Miao Wang; Juan Zhao; Jing Liu; Jie-Mei Yang
Journal:  J Geriatr Cardiol       Date:  2018-01       Impact factor: 3.327

Review 9.  Translational Models and Tools to Reduce Clinical Trials and Improve Regulatory Decision Making for QTc and Proarrhythmia Risk (ICH E14/S7B Updates).

Authors:  David G Strauss; Wendy W Wu; Zhihua Li; John Koerner; Christine Garnett
Journal:  Clin Pharmacol Ther       Date:  2021-01-07       Impact factor: 6.875

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.